| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue |
-
|
-
|
-
| | Cost of Revenue |
-
|
-
|
-
| | | Gross Profit |
-
|
-
|
-
| | | Operating Expenses | | Research Development | 16,104 | 25,321 | 20,919 | | Selling General and Administrative | 10,182 | 7,455 | 6,110 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (26,286) | (32,776) | (27,029) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,043 | 2,039 | (3,116) | | Earnings Before Interest And Taxes | (25,243) | (30,737) | (30,145) | | Interest Expense | 792 | 1,219 |
-
| | Income Before Tax | (26,035) | (31,956) | (30,145) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (26,035) | (31,956) | (30,145) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (26,035) | (31,956) | (30,145) | | Preferred Stock And Other Adjustments |
-
| (4,626) | (11,293) | | | Net Income Applicable To Common Shares | ($26,035) | ($36,582) | ($41,438) |
|
0.30% Nasdaq 
0.11 (1.42%) 
Income Statement
